Document Detail


Intravitreal triamcinolone as primary treatment of cystoid macular edema secondary to branch retinal vein occlusion.
MedLine Citation:
PMID:  16077348     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To describe six patients treated with intravitreal triamcinolone (IVT) as primary therapy for cystoid macular edema (CME) secondary to branch retinal vein occlusion (BRVO). METHODS: Retrospective case series. RESULTS: The age of the patients ranged from 53 years to 87 years (mean, 66 years). The time between BRVO and treatment with IVT ranged from 2.0 months to 4.7 months (mean, 3.5 months). Pretreatment visual acuity ranged from 20/40 to 6/200 (mean, 20/166). Length of follow-up ranged from 107 days to 175 days (mean, 149.5 days). Final visual acuity ranged from 20/40 to 3/200 (mean, 20/137). Three of six eyes showed improvement in vision. All three patients who did not have vision improvement were treated with a second injection. At the final follow-up visit, all six eyes had improved vision from baseline. Five (83.3%) of six eyes showed an improvement of > or = 2 lines of vision. One patient had a postoperative rise in intraocular pressure requiring a trabeculectomy. Final visual acuity in the 6 eyes ranged from 20/200 to 20/30 (mean, 20/106). CONCLUSION: IVT may be of potential use in treating CME due to BRVO, as either a primary or an adjunctive treatment modality. A prospective, randomized trial to clarify this role is warranted.
Authors:
Henry Lee; Gaurav K Shah
Related Documents :
19951598 - Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch...
23731998 - Crystalloids vs. colloids: ko at the twelfth round?
2558708 - Long-term outpatient treatment of cmv retinitis with ganciclovir in aids patients.
24063828 - Outcomes of adolescents and adults undergoing primary fontan procedure.
22939108 - Methylprednisolone use is associated with endothelial cell activation following cardiac...
19196748 - Ultrasound-guided artificial insemination: a randomized controlled trial.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Retina (Philadelphia, Pa.)     Volume:  25     ISSN:  0275-004X     ISO Abbreviation:  Retina (Philadelphia, Pa.)     Publication Date:    2005 Jul-Aug
Date Detail:
Created Date:  2005-08-03     Completed Date:  2005-08-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8309919     Medline TA:  Retina     Country:  United States    
Other Details:
Languages:  eng     Pagination:  551-5     Citation Subset:  IM    
Affiliation:
Barnes Retina Institute and Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri 63144, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Female
Glucocorticoids / therapeutic use*
Humans
Injections
Intraocular Pressure
Macular Edema / diagnosis,  drug therapy*,  etiology*
Male
Middle Aged
Pilot Projects
Retinal Vein Occlusion / complications*
Retreatment
Retrospective Studies
Tomography, Optical Coherence
Triamcinolone Acetonide / therapeutic use*
Visual Acuity
Vitreous Body
Chemical
Reg. No./Substance:
0/Glucocorticoids; 76-25-5/Triamcinolone Acetonide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Combined acute traumatic aortic injury and left main bronchus transection in a 5-year-old child.
Next Document:  Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrect...